Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1975 3
1976 2
1985 1
1986 1
1988 1
1989 4
1990 2
1992 2
1993 2
1994 2
1995 1
1996 4
1997 2
1998 3
1999 1
2000 5
2001 7
2002 3
2003 6
2004 7
2005 5
2006 4
2007 3
2008 3
2009 9
2010 4
2011 2
2018 1
2019 2
2020 3
2021 8
2022 6
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Results by year

Filters applied: . Clear all
Page 1
Asthma and COVID-19: do we finally have answers?
Eger K, Bel EH. Eger K, et al. Eur Respir J. 2021 Mar 4;57(3):2004451. doi: 10.1183/13993003.04451-2020. Print 2021 Mar. Eur Respir J. 2021. PMID: 33380511 Free PMC article.
The emergence of new biologics for severe asthma.
Eger KA, Bel EH. Eger KA, et al. Curr Opin Pharmacol. 2019 Jun;46:108-115. doi: 10.1016/j.coph.2019.05.005. Epub 2019 Jun 21. Curr Opin Pharmacol. 2019. PMID: 31229937 Review.
Evaluation of real-world mepolizumab use in severe asthma across Europe: the SHARP experience with privacy-preserving federated analysis.
Kroes JA, Alfonso-Cristancho R, Bansal AT, Berret E, Bieksiene K, Bourdin A, Brussino L, Canhoto D, Cardini C, Celik G, Csoma Z, Dahlén B, Damadoglu E, Eger K, Gauquelin L, Gemicioglu B, Goksel O, Graff S, Heffler E, Hofstee HB, Howarth P, Jakes RW, Jaun F, Kalinauskaite-Zukauske V, Kopač P, Kwon N, Loureiro CC, Lozoya García V, Masoli M, Rezelj MP, Pérez De Llano L, Popović-Grle S, Ramos-Barbón D, Sà Sousa A, Samitas K, Schleich F, Sirena C, Skrgat S, Zervas E, Zichnalis G, Bel EH, Sont JK, Hashimoto S, Ten Brinke A. Kroes JA, et al. Among authors: eger k. ERJ Open Res. 2023 Apr 3;9(2):00745-2022. doi: 10.1183/23120541.00745-2022. eCollection 2023 Mar. ERJ Open Res. 2023. PMID: 37020841 Free PMC article.
[Progressive limb-girdle muscular dystrophy].
Eger K, Zierz S. Eger K, et al. Dtsch Med Wochenschr. 2001 Jun 1;126(22):655-8. doi: 10.1055/s-2001-14484. Dtsch Med Wochenschr. 2001. PMID: 11450625 Review. German. No abstract available.
The innate immune system and HIV pathogenesis.
Eger KA, Unutmaz D. Eger KA, et al. Curr HIV/AIDS Rep. 2005 Feb;2(1):10-5. doi: 10.1007/s11904-996-0003-4. Curr HIV/AIDS Rep. 2005. PMID: 16091243 Review.
Clinical and morphological phenotype of the filamin myopathy: a study of 31 German patients.
Kley RA, Hellenbroich Y, van der Ven PF, Fürst DO, Huebner A, Bruchertseifer V, Peters SA, Heyer CM, Kirschner J, Schröder R, Fischer D, Müller K, Tolksdorf K, Eger K, Germing A, Brodherr T, Reum C, Walter MC, Lochmüller H, Ketelsen UP, Vorgerd M. Kley RA, et al. Among authors: eger k. Brain. 2007 Dec;130(Pt 12):3250-64. doi: 10.1093/brain/awm271. Brain. 2007. PMID: 18055494 Review.
COVID-19 vaccination acceptance, safety and side-effects in European patients with severe asthma.
Bossios A, Bacon AM, Eger K, Paróczai D, Schleich F, Hanon S, Sergejeva S, Zervas E, Katsoulis K, Aggelopoulou C, Kostikas K, Gaki E, Rovina N, Csoma Z, Grisle I, Bieksiené K, Palacionyte J, Ten Brinke A, Hashimoto S, Mihălţan F, Nenasheva N, Zvezdin B, Čekerevac I, Hromiš S, Ćupurdija V, Lazic Z, Chaudhuri R, Smith SJ, Rupani H, Haitchi HM, Kurukulaaratchy R, Fulton O, Frankemölle B, Howarth P, Porsbjerg C, Bel EH, Djukanovic R, Hyland ME. Bossios A, et al. Among authors: eger k. ERJ Open Res. 2023 Nov 27;9(6):00590-2023. doi: 10.1183/23120541.00590-2023. eCollection 2023 Nov. ERJ Open Res. 2023. PMID: 38020570 Free PMC article.
Real-World Effectiveness of Reslizumab in Patients With Severe Eosinophilic Asthma - First Initiators and Switchers.
Hashimoto S, Kroes JA, Eger KA, Mau Asam PF, Hofstee HB, Bendien SA, Braunstahl GJ, Broeders MEAC, Imming LM, Langeveld B, Maitland-van der Zee AH, Oud KTM, Patberg KW, Smeenk FWJM, Romme EAPM, van Bezouw MJ, van de Ven MJ, van Veen A, van Velzen E, van Veen IHPAA, Weersink EJM, Ten Brinke A, Sont JK, Bel EH; RAPSODI team. Hashimoto S, et al. Among authors: eger ka. J Allergy Clin Immunol Pract. 2022 Aug;10(8):2099-2108.e6. doi: 10.1016/j.jaip.2022.04.014. Epub 2022 Apr 26. J Allergy Clin Immunol Pract. 2022. PMID: 35487369 Free article.
104 results